ImmunityBio, Inc. today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve ...
17 h
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
The CDC first recommended annual flu shots for all children 6 months and older in 2008, when it expanded the recommendation to include school-aged children 5 to 18 years old. The agency had already ...
m project drew outrage over ethical questions about withholding vaccines proven to prevent disease ...
News Medical on MSN
Brain stimulation device cleared for ADHD in the US is overall safe but ineffective
Evidence from a new large UK multicentre trial is challenging the results from a previous smaller US trial that led to the ...
News Medical on MSN
New research compares different wellbeing-focused interventions delivered to adults
As another new year gets under way many of us will be looking for a way of boosting how we feel but is it better to hit the gym or mediate in nature? Now new research by Swansea experts has provided ...
This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...
Health and Me on MSN
Fact check: Are fewer childhood vaccines really a better thing under the new CDC guidelines?
Fact Check examines the CDC’s decision to drop universal recommendations for six childhood vaccines under the Trump ...
A 150-child trial found an FDA-cleared ADHD stimulation device did not significantly reduce symptoms, raising concerns over ...
A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...
Abbvie (ABBV) announced an update on their ongoing clinical study.
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile
Părere